News: Biomerieux SA (BIOX.PA)

BIOX.PA on Paris Stock Exchange

78.80EUR
11:35am EDT
Price Change (% chg)

€-0.09 (-0.11%)
Prev Close
€78.89
Open
€78.89
Day's High
€79.06
Day's Low
€78.54
Volume
26,741
Avg. Vol
21,151
52-wk High
€83.95
52-wk Low
€72.21

Search Stocks
Select another date:

Wed, Oct 22 2014

BRIEF-Biomerieux Q3 revenue rises to 412.0 million euros

* Q3 revenue 412.0 million euros versus 390 million euros last year

BioMerieux working to get FDA approval for Ebola screening test

- BioMerieux SA is working with U.S. health regulators to determine if its test to screen for bio threats could be used to detect the Ebola virus, spokeswoman Suzanne Jones said.

BioMerieux working to get FDA approval for Ebola screening test

Oct 20 - BioMerieux SA is working with U.S. health regulators to determine if its test to screen for bio threats could be used to detect the Ebola virus, spokeswoman Suzanne Jones said.

BRIEF-Biomerieux reports lower H1 operating income

* H1 contributive operating income before non-recurring items 94 million euros versus 125 million euros in H1 2013

Select another date:
Search Stocks